. 2021 Jan;25(1):104-105.

doi: 10.5005/jp-journals-10071-23709.

Post-COVID-19 Pulmonary Fibrosis: A Lifesaving Challenge

Jay Prakash¹, Pradip K Bhattacharya¹, Shio Priye², Naveen Kumar³

Affiliations

¹ Department of Critical Care Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.
² Department of Superspeciality Anesthesia, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.
³ Department of Radiodiagnosis, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.

PMID: 33603312
PMCID: PMC7874295
DOI: 10.5005/jp-journals-10071-23709

Post-COVID-19 Pulmonary Fibrosis: A Lifesaving Challenge

Jay Prakash et al. Indian J Crit Care Med. 2021 Jan.

. 2021 Jan;25(1):104-105.

doi: 10.5005/jp-journals-10071-23709.

Authors

Jay Prakash¹, Pradip K Bhattacharya¹, Shio Priye², Naveen Kumar³

Affiliations

¹ Department of Critical Care Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.
² Department of Superspeciality Anesthesia, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.
³ Department of Radiodiagnosis, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.

PMID: 33603312
PMCID: PMC7874295
DOI: 10.5005/jp-journals-10071-23709

Abstract

How to cite this article: Prakash J, Bhattacharya PK, Priye S, Kumar N. Post-COVID-19 Pulmonary Fibrosis: A Lifesaving Challenge. Indian J Crit Care Med 2021;25(1):104-105.

Keywords: Consequences; Coronavirus disease 2019; Pulmonary fibrosis.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

Figures

**Figs 1A and B**
HRCT showing patchy opacities with small areas of ground-glass opacities and fibrotic bands seen predominantly in the periphery of both lungs with apicobasal gradient

See this image and copyright information in PMC

Cited by

Influenza, SARS-CoV-2, and Their Impact on Chronic Lung Diseases and Fibrosis: Exploring Therapeutic Options.
Soni S, Antonescu L, Ro K, Horowitz JC, Mebratu YA, Nho RS. Soni S, et al. Am J Pathol. 2024 Oct;194(10):1807-1822. doi: 10.1016/j.ajpath.2024.06.004. Epub 2024 Jul 18. Am J Pathol. 2024. PMID: 39032604 Review.
Cardiovascular, Pulmonary, and Neuropsychiatric Short- and Long-Term Complications of COVID-19.
Kobusiak-Prokopowicz M, Fułek K, Fułek M, Kaaz K, Mysiak A, Kurpas D, Beszłej JA, Brzecka A, Leszek J. Kobusiak-Prokopowicz M, et al. Cells. 2022 Dec 1;11(23):3882. doi: 10.3390/cells11233882. Cells. 2022. PMID: 36497138 Free PMC article. Review.
Lung fibrosis: Post-COVID-19 complications and evidences.
Hirawat R, Jain N, Aslam Saifi M, Rachamalla M, Godugu C. Hirawat R, et al. Int Immunopharmacol. 2023 Mar;116:109418. doi: 10.1016/j.intimp.2022.109418. Epub 2022 Nov 4. Int Immunopharmacol. 2023. PMID: 36736220 Free PMC article. Review.
High-flow Nasal Oxygen Therapy in COVID-19 Critically Ill Patients with Acute Hypoxemic Respiratory Failure: A Prospective Observational Cohort Study.
Khan MS, Prakash J, Banerjee S, Bhattacharya PK, Kumar R, Nirala DK. Khan MS, et al. Indian J Crit Care Med. 2022 May;26(5):596-603. doi: 10.5005/jp-journals-10071-24167. Indian J Crit Care Med. 2022. PMID: 35719441 Free PMC article.
Computed tomography severity score as a predictor of disease severity and mortality in COVID-19 patients: A systematic review and meta-analysis.
Prakash J, Kumar N, Saran K, Yadav AK, Kumar A, Bhattacharya PK, Prasad A. Prakash J, et al. J Med Imaging Radiat Sci. 2023 Jun;54(2):364-375. doi: 10.1016/j.jmir.2023.02.003. Epub 2023 Feb 16. J Med Imaging Radiat Sci. 2023. PMID: 36907753 Free PMC article.

See all "Cited by" articles

References

1. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int https://covid19.who.int
1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi: 10.1001/jama.2020.1585. DOI: - DOI - PMC - PubMed
1. Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Casa GD. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med. 2020;8(8):750–752. doi: 10.1016/S2213-2600(20)30222-8. DOI: - DOI - PMC - PubMed
1. George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8(8):807–815. doi: 10.1016/S2213-2600(20)30225-3. DOI: - DOI - PMC - PubMed
1. Sime PJ, O'Reilly KM. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol. 2001;99(3):308–319. doi: 10.1006/clim.2001.5008. DOI: - DOI - PubMed

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Post-COVID-19 Pulmonary Fibrosis: A Lifesaving Challenge

Affiliations

Post-COVID-19 Pulmonary Fibrosis: A Lifesaving Challenge

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources

Other Literature Sources

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources